Imatinib mesylate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

759 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	56	162	53	22	55	319
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	50	128	44	22	57	277
Myeloid leukemia	D007951	—	C92	44	116	38	19	48	244
Gastrointestinal stromal tumors	D046152	EFO_0000505	C49.A	27	78	30	5	28	157
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	18	47	15	2	5	76
Myeloid leukemia chronic-phase	D015466	—	—	18	37	10	6	11	76
Lymphoid leukemia	D007945	—	C91	19	43	12	2	5	70
Philadelphia chromosome	D010677	—	—	12	30	15	3	3	53
Blast crisis	D001752	—	—	10	16	1	2	3	28
Covid-19	D000086382	—	U07.1	—	4	4	2	—	10

Show 13 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	19	28	1	—	6	51
Recurrence	D012008	—	—	5	12	2	—	2	19
Sarcoma	D012509	—	—	3	15	3	—	—	18
Myeloid leukemia accelerated phase	D015465	—	—	7	7	1	—	—	13
Hypertension	D006973	EFO_0000537	I10	1	4	8	—	2	13
Lymphoma	D008223	—	C85.9	4	9	1	—	—	12
Pulmonary arterial hypertension	D000081029	—	—	1	3	8	—	1	11
Graft vs host disease	D006086	—	D89.81	1	4	3	—	—	8
Glioblastoma	D005909	EFO_0000515	—	2	4	2	—	—	8
Familial primary pulmonary hypertension	D065627	—	I27.0	—	3	7	—	—	8

Show 23 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Syndrome	D013577	—	—	3	12	—	—	1	15
Melanoma	D008545	—	—	5	13	—	—	—	14
Lung neoplasms	D008175	—	C34.90	3	11	—	—	—	13
Myeloid leukemia acute	D015470	—	C92.0	5	8	—	—	1	12
Carcinoma	D002277	—	C80.0	6	8	—	—	—	11
Neoplasm metastasis	D009362	EFO_0009708	—	3	7	—	—	1	11
Prostatic neoplasms	D011471	—	C61	4	7	—	—	—	10
Hypereosinophilic syndrome	D017681	EFO_1001467	D72.11	2	7	—	—	1	9
Myelomonocytic leukemia chronic	D015477	—	C93.1	3	4	—	—	1	8
Myelomonocytic leukemia juvenile	D054429	—	C93.3	3	4	—	—	1	8

Show 163 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Healthy volunteers/patients	—	—	—	11	—	—	—	—	11
Acute disease	D000208	—	—	1	—	—	—	1	2
Hodgkin disease	D006689	—	C81	2	—	—	—	—	2
Leukemia myeloid chronic atypical bcr-abl negative	D054438	—	C92.2	2	—	—	—	—	2
Myelodysplastic-myeloproliferative diseases	D054437	—	—	2	—	—	—	—	2
Castration-resistant prostatic neoplasms	D064129	—	—	1	—	—	—	—	1
Anemia	D000740	EFO_0004272	D64.9	1	—	—	—	—	1
Plasma cell neoplasms	D054219	—	—	1	—	—	—	—	1
Hiv infections	D015658	EFO_0000764	B20	1	—	—	—	—	1
Papillary thyroid cancer	D000077273	—	—	1	—	—	—	—	1

Show 44 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Renal insufficiency	D051437	—	N19	—	—	—	—	1	1
Mouth neoplasms	D009062	EFO_0003868	C06.9	—	—	—	—	1	1
Fatigue	D005221	—	R53.83	—	—	—	—	1	1
Disease-free survival	D018572	EFO_0000409	—	—	—	—	—	1	1
Germ-line mutation	D018095	—	—	—	—	—	—	1	1
Triple negative breast neoplasms	D064726	—	—	—	—	—	—	1	1
Chronic renal insufficiency	D051436	—	N18	—	—	—	—	1	1
Kidney diseases	D007674	EFO_0003086	N08	—	—	—	—	1	1